Literature DB >> 11000270

A pathogenic point mutation reduces stability of mitochondrial mutant tRNA(Ile).

T Yasukawa1, N Hino, T Suzuki, K Watanabe, T Ueda, S Ohta.   

Abstract

Point mutations in mitochondrial tRNA genes are responsible for individual subgroups of mitochondrial encephalomyopathies. We have recently reported that point mutations in the tRNA(Leu)(UUR) and tRNA(Lys) genes cause a defect in the normal modification at the first nucleotide of the anticodon. As part of a systematic analysis of pathogenic mutant mitochondrial tRNAs, we purified tRNA(Ile) with a point mutation at nucleotide 4269 to determine its nucleotide sequence, including modified nucleotides. We found that, instead of causing a defect in the post-transcriptional modification, a pathogenic point mutation in the mitochondrial tRNA(Ile) reduced the stability of the mutant tRNA molecule, resulting in a low steady-state level of aminoacyl-tRNA. The reduced stability was confirmed by examining the life-span of the mutant tRNA(Ile) both in vitro and in vivo, as well as by monitoring its melting profile. Our finding indicates that the mutant tRNA(Ile) itself is intrinsically unstable.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000270      PMCID: PMC110767          DOI: 10.1093/nar/28.19.3779

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Compilation of tRNA sequences and sequences of tRNA genes.

Authors:  M Sprinzl; C Horn; M Brown; A Ioudovitch; S Steinberg
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

2.  Pathophysiology of the MELAS 3243 transition mutation.

Authors:  A Flierl; H Reichmann; P Seibel
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

Review 3.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

4.  Bovine mitochondrial initiation and elongation factors.

Authors:  C J Schwartzbach; M Farwell; H X Liao; L L Spremulli
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

5.  Isoleucylation properties of native human mitochondrial tRNAIle and tRNAIle transcripts. Implications for cardiomyopathy-related point mutations (4269, 4317) in the tRNAIle gene.

Authors:  F Degoul; H Brulé; C Cepanec; M Helm; C Marsac; J Leroux; R Giegé; C Florentz
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

6.  Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function.

Authors:  J Hayashi; S Ohta; D Takai; S Miyabayashi; R Sakuta; Y Goto; I Nonaka
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

7.  Molecular recognition of the identity-determinant set of isoleucine transfer RNA from Escherichia coli.

Authors:  O Nureki; T Niimi; T Muramatsu; H Kanno; T Kohno; C Florentz; R Giegé; S Yokoyama
Journal:  J Mol Biol       Date:  1994-02-25       Impact factor: 5.469

8.  MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination.

Authors:  J A Enriquez; A Chomyn; G Attardi
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

Review 9.  Human mitochondrial diseases: answering questions and questioning answers.

Authors:  N Howell
Journal:  Int Rev Cytol       Date:  1999

10.  Functional and morphological abnormalities of mitochondria in human cells containing mitochondrial DNA with pathogenic point mutations in tRNA genes.

Authors:  J Hayashi; S Ohta; Y Kagawa; D Takai; S Miyabayashi; K Tada; H Fukushima; K Inui; S Okada; Y Goto
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

View more
  13 in total

Review 1.  Disease-related versus polymorphic mutations in human mitochondrial tRNAs. Where is the difference?

Authors:  C Florentz; M Sissler
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

2.  Pathology-related substitutions in human mitochondrial tRNA(Ile) reduce precursor 3' end processing efficiency in vitro.

Authors:  Louis Levinger; Richard Giegé; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

Review 3.  Mitochondrial tRNA 3' end metabolism and human disease.

Authors:  Louis Levinger; Mario Mörl; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

4.  Evidence for the presence of somatic mitochondrial DNA mutations in right atrial appendage tissues of coronary artery disease patients.

Authors:  Kavitha Matam; Noor Ahmad Shaik; Sunil Aggarwal; Sameer Diwale; Babajan Banaganapalli; Jumana Yousuf Al-Aama; Ramu Elango; Pragna Rao; Qurratulain Hasan
Journal:  Mol Genet Genomics       Date:  2014-03-07       Impact factor: 3.291

5.  Decreased mitochondrial tRNALys steady-state levels and aminoacylation are associated with the pathogenic G8313A mitochondrial DNA mutation.

Authors:  Sandra R Bacman; David P Atencio; Carlos T Moraes
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

6.  The pathogenic U3271C human mitochondrial tRNA(Leu(UUR)) mutation disrupts a fragile anticodon stem.

Authors:  Lisa M Wittenhagen; Marc D Roy; Shana O Kelley
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

7.  Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutations.

Authors:  Raquel Moreno-Loshuertos; Gustavo Ferrín; Rebeca Acín-Pérez; M Esther Gallardo; Carlo Viscomi; Acisclo Pérez-Martos; Massimo Zeviani; Patricio Fernández-Silva; José Antonio Enríquez
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

8.  Partial tandem duplication of mtDNA-tRNA(Phe) impairs mtDNA translation in late-onset mitochondrial myopathy.

Authors:  Paola Arzuffi; Costanza Lamperti; Erika Fernandez-Vizarra; Paola Tonin; Lucia Morandi; Massimo Zeviani
Journal:  Neuromuscul Disord       Date:  2012-01-09       Impact factor: 4.296

9.  Molecular dysfunction associated with the human mitochondrial 3302A>G mutation in the MTTL1 (mt-tRNALeu(UUR)) gene.

Authors:  Katharina Maniura-Weber; Mark Helm; Katrin Engemann; Sabrina Eckertz; Myriam Möllers; Matthias Schauen; Armine Hayrapetyan; Jürgen-Christoph von Kleist-Retzow; Robert N Lightowlers; Laurence A Bindoff; Rudolf J Wiesner
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

10.  CO2-sensitive tRNA modification associated with human mitochondrial disease.

Authors:  Huan Lin; Kenjyo Miyauchi; Tai Harada; Ryo Okita; Eri Takeshita; Hirofumi Komaki; Kaoru Fujioka; Hideki Yagasaki; Yu-Ichi Goto; Kaori Yanaka; Shinichi Nakagawa; Yuriko Sakaguchi; Tsutomu Suzuki
Journal:  Nat Commun       Date:  2018-05-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.